Everolimus 5 MG tablet UD 28S
Ended Awarded Last action
- Contract number
- SPE2DR26FM19Q
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,792
Award facts
- Contract value 100% obligated
- $1,791.52 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on December 1, 2025, by the Defense Logistics Agency (DLA) for the supply of Everolimus 5 mg tablets in unit dose packaging. This is a firm fixed-price delivery order with a ceiling value of $1,791.52 and an ultimate completion date of December 2, 2025. The contract carries no set-aside designation, indicating it was competitively awarded. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026, which serves as the primary vehicle for global pharmaceutical support to military healthcare programs.
AmerisourceBergen's role as a pharmaceutical prime vendor enables the company to supply critical medical commodities across multiple therapeutic domains to support Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. The DLA maintains this strategic vendor relationship to ensure reliable access to both brand-name and generic medications, including specialty pharmaceuticals like Everolimus, an immunosuppressant medication commonly used in transplant and oncology applications. As a major component of the DLA's medical supply chain, AmerisourceBergen's contract portfolio reflects the agency's commitment to maintaining robust pharmaceutical procurement capabilities for military and veteran healthcare delivery.
Quick answers
Who was awarded contract SPE2DR26FM19Q?
SPE2DR26FM19Q was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 1, 2025.
How much is contract SPE2DR26FM19Q worth?
The government has obligated $1,792 on SPE2DR26FM19Q.
Is contract SPE2DR26FM19Q an order under another contract?
Yes. SPE2DR26FM19Q is a delivery order under SPE2DR25D2007, an indefinite delivery contract.
Was contract SPE2DR26FM19Q competed?
The extent of competition for SPE2DR26FM19Q was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award